UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS – No

Multiple sclerosis, 2019-02, Vol.25 (2), p.189-190

Hellwig, Kerstin

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD20 therapy in pregnancy: Balancing risks and benefits

Multiple sclerosis, 2024-02, Vol.30 (2), p.274-275

2024

Link zum Volltext

Verfügbarkeit prüfen

What if? Is a good solution good enough?

Multiple sclerosis, 2021-04, Vol.27 (5), p.651-652

2021

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab during pregnancy and lactation

Multiple sclerosis, 2018-10, Vol.24 (12), p.1627-1634

2018

Link zum Volltext

Verfügbarkeit prüfen

Smouldering multiple sclerosis: the ‘real MS’

Therapeutic Advances in Neurological Disorders, 2022-01, Vol.15, p.17562864211066751-17562864211066751

2022

Link zum Volltext

Verfügbarkeit prüfen

MS, pregnancy and COVID-19

Multiple Sclerosis Journal, 2020-09, Vol.26 (10), p.1137-1146

2020

Link zum Volltext

Verfügbarkeit prüfen

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry

Scientific reports, 2021-06, Vol.11 (1), p.13340-13340, Article 13340

2021

Link zum Volltext

Verfügbarkeit prüfen

Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations

Nature reviews. Neurology, 2020-03, Vol.16 (3), p.154-170

2020

Link zum Volltext

Verfügbarkeit prüfen

Low transfer of cladribine into human milk

Multiple sclerosis, 2023-09, Vol.29 (10), p.1346-1347

2023

Link zum Volltext

Verfügbarkeit prüfen

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results

Therapeutic advances in neurological disorders, 2021-11, Vol.14, p.17562864211054956-17562864211054956

2021

Link zum Volltext

Verfügbarkeit prüfen

Cladribine and pregnancy in women with multiple sclerosis: The first cohort study

Multiple sclerosis, 2023-03, Vol.29 (3), p.461-465

2023

Link zum Volltext

Verfügbarkeit prüfen

Exposure to natalizumab during pregnancy and lactation is safe – Commentary

Multiple sclerosis, 2020-07, Vol.26 (8), p.892-893

2020

Link zum Volltext

Verfügbarkeit prüfen

Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study

Multiple sclerosis, 2022-09, Vol.28 (10), p.1641-1650

2022

Link zum Volltext

Verfügbarkeit prüfen

Schwangerschaft und Multiple Sklerose

InFo Neurologie + Psychiatrie, 2023-04, Vol.25 (4), p.25-25

Hellwig, Kerstin

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis

Multiple sclerosis, 2020-10, Vol.26 (11), p.1410-1419

2020

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis

Therapeutic Advances in Neurological Disorders, 2021, Vol.14, p.17562864211051012-17562864211051012

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany

Therapeutic advances in neurological disorders, 2012-09, Vol.5 (5), p.247-253

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Journal of neurology, neurosurgery and psychiatry, 2017-08, Vol.88 (8), p.639

2017

Link zum Volltext

Verfügbarkeit prüfen

Cladribine transfer into human milk: A case report

Multiple sclerosis, 2021-04, Vol.27 (5), p.799-801

2021

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry

Multiple sclerosis, 2024-02, Vol.30 (2), p.209-215

2024

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab for multiple sclerosis: the dilemma of NOVA

Lancet neurology, 2022-07, Vol.21 (7), p.579-581

Hellwig, Kerstin

2022

Link zum Volltext

Verfügbarkeit prüfen

Sex effects across the lifespan in women with multiple sclerosis

Therapeutic Advances in Neurological Disorders, 2020, Vol.13, p.175628642093616-1756286420936166

2020

Link zum Volltext

Verfügbarkeit prüfen

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

Journal of neurology, neurosurgery and psychiatry, 2013-10, Vol.84 (10), p.1068-1074

2013

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

Journal of neurology, 2020-06, Vol.267 (6), p.1715-1723

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(210)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS – No

Anti-CD20 therapy in pregnancy: Balancing risks and benefits

What if? Is a good solution good enough?

Natalizumab during pregnancy and lactation

Smouldering multiple sclerosis: the ‘real MS’

MS, pregnancy and COVID-19

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry

Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations

Low transfer of cladribine into human milk

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results

Cladribine and pregnancy in women with multiple sclerosis: The first cohort study

Exposure to natalizumab during pregnancy and lactation is safe – Commentary

Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study

Schwangerschaft und Multiple Sklerose

Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis

A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Cladribine transfer into human milk: A case report

Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry

Natalizumab for multiple sclerosis: the dilemma of NOVA

Sex effects across the lifespan in women with multiple sclerosis

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

Suchergebnisse filtern